ADMA Court News: ADMA Biologics Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses

A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK, July 14, 2026 /PRNewswire/ -- Leading securities law firm...